Analystreport

Zosano Pharma Co. (NASDAQ: ZSAN) had its price target lowered by analysts at HC Wainwright from $2.50 to $2.00. They now have a "buy" rating on the stock.

Zosano Pharma Corporation  (ZSAN) 
Last zosano pharma corporation earnings: 11/9 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.zosanopharma.com